Trials / Completed
CompletedNCT00342277
Microarray Expression Profiling to Identify Stereotypic mRNA Profiles in Human Parturition
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 6,838 (actual)
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · NIH
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The understanding of the biological mechanisms underlying preterm birth is very limited, making prevention of preterm birth difficult. The incidence of preterm birth worldwide varies between 6%-11% in singleton pregnancies, and 64-93% of preterm deliveries occur after the spontaneous onset of labor (preterm labor). The risk factors associated with preterm birth include demographic variables such as ethnic group, past obstetric history, and complications of the current pregnancy such as infection and fetal congenital anomalies. The current study aims to investigate the basic mechanisms of preterm labor by systematically cataloging the changes in expression levels of all expressed genes whose sequences are available. The goals will be accomplished by using microarray technology followed by subsequent confirmative or complementary analyses.
Detailed description
The understanding of the biological mechanisms underlying preterm birth is very limited, making prevention of preterm birth difficult. The incidence of preterm birth worldwide varies between 6%-11% in singleton pregnancies, and 64-93% of preterm deliveries occur after the spontaneous onset of labor (preterm labor). The risk factors associated with preterm birth include demographic variables such as ethnic group, past obstetric history, and complications of the current pregnancy such as infection and fetal congenital anomalies. The current study aims to investigate the basic mechanisms of preterm labor by systematically cataloging the changes in expression levels of all expressed genes whose sequences are available. The goals will be accomplished by using microarray technology followed by subsequent confirmative or complementary analyses.
Conditions
Timeline
- Start date
- 1999-12-21
- Primary completion
- 2016-05-05
- Completion
- 2016-05-05
- First posted
- 2006-06-21
- Last updated
- 2023-02-24
Locations
4 sites across 4 countries: United States, Chile, Italy, South Korea
Source: ClinicalTrials.gov record NCT00342277. Inclusion in this directory is not an endorsement.